These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 10815287)
1. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?]. Edan G; Coustans M Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of progressive forms of multiple sclerosis]. Edan G Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1008-13. PubMed ID: 11787331 [TBL] [Abstract][Full Text] [Related]
3. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
6. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials]. Ozawa K; Saida T Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444 [TBL] [Abstract][Full Text] [Related]
9. Non-specific immunosuppressants in the treatment of multiple sclerosis. Confavreux C; Vukusic S Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive medication in multiple sclerosis]. García Merino JA Rev Neurol; 2002 Dec 16-31; 35(12):1154-8. PubMed ID: 12497298 [TBL] [Abstract][Full Text] [Related]
12. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443 [TBL] [Abstract][Full Text] [Related]
13. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis. Goodkin DE West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569 [TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis: diagnostic procedures and current therapeutic developments]. Kappos L Schweiz Med Wochenschr; 1995 Jun; 125(25):1251-63. PubMed ID: 7610362 [TBL] [Abstract][Full Text] [Related]
15. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
16. Intensive immunosuppression in multiple sclerosis. Zaffaroni M; Ghezzi A; Comi G Neurol Sci; 2006 Mar; 27 Suppl 1():S13-7. PubMed ID: 16708175 [TBL] [Abstract][Full Text] [Related]
17. Lessons from randomised direct comparative trials. Achiron A; Fredrikson S J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860 [TBL] [Abstract][Full Text] [Related]
18. [Mitoxantrone for the treatment of patients with multiple sclerosis]. Komori M; Kondo T; Tanaka M Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518 [TBL] [Abstract][Full Text] [Related]